Doma Katarina M, Lewis Erin D, Barracato Jane M, Brink Lauren R, Gratson Alejandra A, Pandey Neeraj, Crowley David C, Evans Malkanthi
KGK Science Inc, 275 Dundas Street, Tower A Suite A1605, London, ON, N6B 3L1, Canada.
Global Medical Science, Reckitt, 399 Interpace Parkway, P.O. Box 225, Parsippany, NJ, 07054-0225, USA.
Neurol Ther. 2023 Jun;12(3):777-794. doi: 10.1007/s40120-023-00454-z. Epub 2023 Mar 16.
Cognition refers to brain functions including memory, learning, and thought processing and is increasingly important to individuals. However, impairment of cognitive function is a concern among North American adults. Therefore, effective and reliable treatments are needed.
This randomized, double-blind, placebo-controlled study examined the effects of 42 days of Neuriva® supplementation, a whole coffee cherry extract and phosphatidylserine supplement, on memory, accuracy, focus and concentration and learning among 138 healthy adults (40-65 years) with self-reported memory problems. Plasma brain-derived neurotrophic factor (BDNF) levels, Computerized Mental Performance Assessment System (COMPASS) tasks, the Everyday Memory Questionnaire (EMQ), and Go/No-Go tests were assessed at baseline and day 42.
As compared to placebo, Neuriva® supplementation elicited greater improvements at day 42 in numeric working memory COMPASS task accuracy outcomes (p ≤ 0.024) which assessed memory, accuracy, and focus and concentration, and reaction time outcomes (p ≤ 0.031) which assessed memory as well as focus and concentration. Neuriva® supplementation improved overall accuracy (p = 0.035) in the picture recognition task that assessed memory, accuracy, and learning compared to placebo. No significant differences between groups were observed for BDNF, the EMQ, or Go/No-Go tests.
Results suggest 42 days of Neuriva® supplementation was safe, well tolerated, and beneficial in improving memory, accuracy, focus and concentration, and learning in a healthy adult population with self-reported memory problems.
认知是指包括记忆、学习和思维处理在内的大脑功能,对个体而言愈发重要。然而,认知功能受损是北美成年人所关注的问题。因此,需要有效且可靠的治疗方法。
本随机、双盲、安慰剂对照研究,对138名(40 - 65岁)自我报告有记忆问题的健康成年人补充Neuriva®(一种全咖啡樱桃提取物和磷脂酰丝氨酸补充剂)42天,观察其对记忆、准确性、注意力集中程度和学习能力的影响。在基线期和第42天评估血浆脑源性神经营养因子(BDNF)水平、计算机化心理表现评估系统(COMPASS)任务、日常记忆问卷(EMQ)以及Go/No-Go测试。
与安慰剂相比,补充Neuriva®在第42天时,数字工作记忆COMPASS任务准确性结果(评估记忆、准确性、注意力集中程度,p≤0.024)以及反应时间结果(评估记忆以及注意力集中程度,p≤0.031)有更大改善。与安慰剂相比,补充Neuriva®在评估记忆、准确性和学习能力的图片识别任务中提高了总体准确性(p = 0.035)。在BDNF、EMQ或Go/No-Go测试中,两组间未观察到显著差异。
结果表明,对于自我报告有记忆问题的健康成年人群,补充Neuriva® 42天是安全的,耐受性良好,且有助于改善记忆、准确性、注意力集中程度和学习能力。